Showing results (1-10 of 924) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|May 4, 2019
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trialEmanuele Bosi, Pratik Choudhary, Harold W de Valk, et al.The Lancet. Diabetes & Endocrinology|July 31, 2016
An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trialPaul Little, Beth Stuart, Fd Richard Hobbs, et al.The Lancet. Diabetes & Endocrinology|May 6, 2023
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trialAthena Philis-Tsimikas, Marisse Asong, Edward Franek, et al.The Lancet. Diabetes & Endocrinology|August 28, 2025
Prolactin-secreting adenomas: pathogenesis, diagnosis, and managementMaria Fleseriu, Elena V Varlamov, Amit Akirov, et al.The Lancet. Diabetes & Endocrinology|June 26, 2015
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participantsThe Lancet. Diabetes & Endocrinology|June 15, 2015
Nutritional support in critical illness and recoveryMichael P Casaer, Thomas R ZieglerThe Lancet. Diabetes & Endocrinology|June 2, 2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant dataKunihiro Matsushita, Josef Coresh, Yingying Sang, et al.The Lancet. Diabetes & Endocrinology|July 17, 2015
Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trialSaloua El Messaoudi, Rianne Nederlof, Coert J Zuurbier, et al.The Lancet. Diabetes & Endocrinology|June 13, 2015
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trialAhmad Haidar, Laurent Legault, Laurence Matteau-Pelletier, et al.Pageof 93